Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study

被引：0
|
作者：
Makoto Naganuma
Shinya Sugimoto
Tomohiro Fukuda
Keiichi Mitsuyama
Taku Kobayashi
Naoki Yoshimura
Hidehisa Ohi
Shinji Tanaka
Akira Andoh
Naoki Ohmiya
Keiichiro Saigusa
Takayuki Yamamoto
Yuichi Morohoshi
Hitoshi Ichikawa
Katsuyoshi Matsuoka
Tadakazu Hisamatsu
Kenji Watanabe
Shinta Mizuno
Takayuki Abe
Yasuo Suzuki
Takanori Kanai
机构：
[1] Keio University School of Medicine,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[2] Kurume University School of Medicine,Division of Gastroenterology, Department of Medicine
[3] Kitasato University Kitasato Institute Hospital,Center for Advanced IBD Research and Treatment
[4] Tokyo Yamate Medical Center,Department of Internal Medicine, Division of IBD
[5] Imamura Hospital,Department of Gastroenterology
[6] Hiroshima University Hospital,Department of Endoscopy and Medicine
[7] Shiga University of Medical Science,Department of Medicine
[8] Fujita Health University School of Medicine,Department of Gastroenterology
[9] Tokyo Saiseikai Central Hospital,Department of Medicine
[10] Yokkaichi Hazu Medical Center,IBD Center
[11] Yokohama Municipal Citizen’s Hospital,Department of Medicine
[12] Tokai University Hachioji Hospital,Department of Gastroenterology
[13] Toho University Sakura Medical Center,Department of Gastroenterology
[14] Toho University Sakura Medical Center,Department of Internal Medicine
[15] Kyorin University School of Medicine,The Third Department of Internal Medicine
[16] Hyogo College of Medicine,Department of Intestinal Inflammation Research
[17] Keio University School of Medicine,Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical and Translational Research Center
[18] Toho University Sakura Medical Center,Inflammatory Bowel Disease Center
来源：
Journal of Gastroenterology | 2020年 / 55卷
关键词：
Ulcerative colitis; Indigo naturalis; Anti-TNFa treatment; Steroid dependent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：169 / 180
页数：11
相关论文
共 50 条
  • [41] Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis
    Sandborn, William J.
    Colombel, Jean-Frederic
    Panaccione, Remo
    Dulai, Parambir S.
    Rosario, Maria
    Cao, Charlie
    Barocas, Morris
    Lasch, Karen
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (02): : 172 - 181
  • [42] Impact of recent thiopurine use on ozanimod safety in patients with ulcerative colitis: a post hoc analysis of the phase 3 True North study
    Battat, R.
    Panaccione, R.
    Hart, A.
    Hisamatsu, T.
    Ahmad, H. A.
    Osterman, M. T.
    Wu, H.
    Jain, A.
    Rosen, M.
    Siegmund, B.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1100 - I1101
  • [43] EFFECT OF RISANKIZUMAB ON EARLY SYMPTOMS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF THE INSPIRE INDUCTION STUDY
    Siegel, Corey A.
    Rubin, David T.
    Panaccione, Remo
    Rieder, Florian
    Takeuchi, Ken
    Hecht, Patrick
    Levine, Phillip
    Gonzalez, Yuri Sanchez
    Zhang, Yafei
    Vladea, Ramona C.
    Biedermann, Luc
    Wu, Kaichun
    GASTROENTEROLOGY, 2024, 166 (05) : S805 - S805
  • [44] The experience of social support in patients suffering from treatment-refractory depression -: A pilot study
    Skärsäter, I
    Dencker, K
    Ågren, H
    ARCHIVES OF PSYCHIATRIC NURSING, 1999, 13 (02) : 89 - 96
  • [45] Comparing the topical preparations of Indigo naturalis from Chinese and Iranian origin in the treatment of plaque-type psoriasis: A preliminary randomized double-blind pilot study
    Yazdanpanah, Mohammad Javad
    Vahabi-Amlashi, Sadegh
    Pishgouy, Marzieh
    Imani, Mohammad
    Banihashemi, Mahnaz
    Mohammadpoor, Amir Hooshang
    Khajedaluee, Mohammad
    Bahrami-Taghanaki, Hamidreza
    Azizi, Hoda
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2021, 43
  • [46] Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE
    Matsuoka, K.
    Lowenberg, M.
    Fumery, M.
    Takatori, Y.
    Fujitani, Y.
    Oortwijn, A.
    Faes, M.
    Jamoul, C.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I112 - I113
  • [47] Efficacy of Ozanimod in Vedolizumab-Exposed Patients With Ulcerative Colitis: A Phase 3 True North Post Hoc Analysis
    Sands, Bruce E.
    Jain, Anjali
    Ahmad, Harris A.
    Osterman, Mark
    Memaj, Arteid
    Canavan, James B.
    Axelrad, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S593 - S594
  • [48] Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: a phase 3 True North post hoc analysis
    Sands, B. E.
    Jain, A.
    Ahmad, H. A.
    Osterman, M.
    Memaj, A.
    Canavan, J. B.
    Axelrad, J. E.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 507 - 508
  • [49] Efficacy of Ozanimod in Patients With Ulcerative Colitis Who Were Previously Exposed to Vedolizumab: True North Post Hoc Analysis
    Sands, Bruce
    Jain, Anjali
    Harris, Ahmad
    Osterman, Mark
    Memaj, Arteid
    Canavan, James
    Axelrad, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S4 - S4
  • [50] Efficacy and Safety of Etrasimod in Patients With Ulcerative Colitis Stratified by Body Mass Index: A Post Hoc Analysis From the ELEVATE UC Clinical Program
    Yarur, Andres J.
    Long, Millie D.
    Torres, Joana
    Nandi, Neilanjan
    Cross, Raymond K.
    Abbatemarco, Arcangelo M.
    Blanco, David
    Niezychowski, Wojciech
    Crosby, Catherine M.
    Wu, Joseph
    Pradeep, Gokul
    Goetsch, Martina
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1026 - S1027
12345